These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12807576)

  • 21. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
    Martin H; Slyk MP; Deymann S; Cornacchione MJ
    J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France].
    Le Pen C; Lilliu H; Allicar MP; Olivier V; Gregor KJ
    Encephale; 1999; 25(4):281-6. PubMed ID: 10546082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three antipsychotics in the emergency psychiatric setting.
    Raja M; Azzoni A
    Hum Psychopharmacol; 2003 Aug; 18(6):447-52. PubMed ID: 12923822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP; Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.
    Hamilton SH; Revicki DA; Genduso LA; Beasley CM
    Neuropsychopharmacology; 1998 Jan; 18(1):41-9. PubMed ID: 9408917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
    Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J; Inada T; Miura S
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):403-14. PubMed ID: 11442893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost-effectiveness clinical decision analysis model for schizophrenia.
    Palmer CS; Revicki DA; Genduso LA; Hamilton SH; Brown RE
    Am J Manag Care; 1998 Mar; 4(3):345-55. PubMed ID: 10178497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial.
    Berk M; Brook S; Trandafir AI
    Int Clin Psychopharmacol; 1999 May; 14(3):177-80. PubMed ID: 10435771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated with risperidone or olanzapine].
    Hamel B; Courtet P; Vergnes C; Boulenger JP
    Therapie; 2001; 56(6):645-52. PubMed ID: 11878086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atypical antipsychotics in elderly patients with dementia].
    Selbaek G; Engedal K
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
    Angelini A; Bendini C; Neviani F; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.